TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31827656

Group type: EXPERIMENTAL
Intervention: Microdecompression
Number of subjects: 100

Group type: COMPARATOR
Intervention: Open wide laminectomy and posterior stabilization
Number of subjects: 100
Study: 29273089

Group type: EXPERIMENTAL
Intervention: Famitinib
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study: 27262871

Group type: EXPERIMENTAL
Intervention: Progesterone with or without hypothermia (exact dosage and duration not specified)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 107
Study: 24184091

Group type: EXPERIMENTAL
Intervention: Acuvue Oasys
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Air Optix
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Biofinity
Number of subjects: 10

Group type: COMPARATOR
Intervention: Spectacles
Number of subjects: 10
Study: 22341378

Group type: EXPERIMENTAL
Intervention: Stretching of the calf and hamstring muscles nightly for six weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: No specific stretching exercises (Control)
Number of subjects: 80
Study: 20708421

Group type: EXPERIMENTAL
Intervention: 5 mg/mL formulation of rhGH Nutropin AQ
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2.5 mg/mL formulation of rhGH Nutropin AQ
Number of subjects: 0

Group type: COMPARATOR
Intervention: 10 mg/mL formulation of rhGH Nutropin AQ
Number of subjects: 0
Study: 17032732

Group type: EXPERIMENTAL
Intervention: GnRH antagonist Cetrorelix with recombinant FSH (rFSH) in group A (n = 52)
Number of subjects: 104

Group type: COMPARATOR
Intervention: rFSH alone in group B (n = 52)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: GnRH antagonist Cetrorelix with rFSH in group A
Number of subjects: 104

Group type: COMPARATOR
Intervention: rFSH alone in group B
Number of subjects: 104
Study: 16264123

Group type: EXPERIMENTAL
Intervention: Ultrasonographic hip examination
Number of subjects: 629

Group type: COMPARATOR
Intervention: Clinical assessment alone
Number of subjects: 629
Study: 12030546

Group type: EXPERIMENTAL
Intervention: 0.5 mg 17beta-estradiol (E2)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: 1 mg 17beta-estradiol (E2)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: 2 mg 17beta-estradiol (E2)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 166
Study: 9477049

Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 20
Study: 7554335

Group type: EXPERIMENTAL
Intervention: Anterior turbinectomy
Number of subjects: 214

Group type: COMPARATOR
Intervention: Radical turbinectomy
Number of subjects: 214
Study: 1847582

Group type: EXPERIMENTAL
Intervention: Provera 20 mg
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Premarin 0.6 mg
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Premarin 0.3 mg plus Provera 10 mg
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 6841821

Group type: EXPERIMENTAL
Intervention: Pure-tone signals with interaural phase shifts ranging between 90 degrees and 360 degrees, with rise/decay time varied from 5 to 200 ms.
Number of subjects: 0
Study: 30979941

Group type: EXPERIMENTAL
Intervention: Sleep
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wakefulness
Number of subjects: 0
Study: 30414609

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 0.08% alone
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.25% plus ketorolac tromethamine 0.08%
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.25% alone
Number of subjects: 59

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 59
Study: 25870994

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 μg once daily)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 23175179

Group type: EXPERIMENTAL
Intervention: Exercise (3 sets, 8 RM, 9 exercises)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 16
Study: 22054336

Group type: EXPERIMENTAL
Intervention: Tailored package of housing improvements providing adequate ventilation and temperature
Number of subjects: 192
Study: 19420915

Group type: EXPERIMENTAL
Intervention: Endovascular treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 40
Study: 16952918

Group type: EXPERIMENTAL
Intervention: TEA (lidocaine 2 mg kg(‐1) followed by 3 mg kg(‐1) h(‐1) epidurally)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: IV (lidocaine i.v. with normal saline epidurally)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (normal saline via both routes)
Number of subjects: 60
Study: 15298876

Group type: EXPERIMENTAL
Intervention: LMA‐ProSeal
Number of subjects: 60

Group type: COMPARATOR
Intervention: LMA‐Classic
Number of subjects: 60
Study: 11189688

Group type: EXPERIMENTAL
Intervention: Recruitment strategies tailored to individual catchment areas at screening centers
Number of subjects: 150000

Group type: EXPERIMENTAL
Intervention: National level recruitment efforts initiated by the NCI
Number of subjects: 150000
Study: 8828533

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73

Group type: COMPARATOR
Intervention: Oral budesonide
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: DVPF
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: LPF
Number of subjects: 73
Study: 1595097

Group type: EXPERIMENTAL
Intervention: Extracranial-intracranial bypass surgery (group A)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (group B)
Number of subjects: 104
Study: 6731693

Group type: EXPERIMENTAL
Intervention: Sequential pneumatic leg compression at pressures of 90 to 100 mm Hg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sequential pneumatic leg compression at pressures of 35 mm Hg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Heparin 5,000 units three times per day
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sequential pneumatic leg compression at pressures of 35 to 55 mm Hg
Number of subjects: 25
Study: 30564869

Group type: EXPERIMENTAL
Intervention: Minocycline (200 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30019477

Group type: EXPERIMENTAL
Intervention: Transformational leadership of nurse managers
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Structural empowerment of nurses
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Transformational leadership of managers
Number of subjects: 131
Study: 26660709

Group type: EXPERIMENTAL
Intervention: Individual cognitive-behavioural parent training (CBPT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group cognitive-behavioural parent training (CBPT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medication (not specified if it was part of the intervention)
Number of subjects: 0
Study: 25232955

Group type: EXPERIMENTAL
Intervention: Multidisciplinary outpatient rehabilitation (MDR)
Number of subjects: 48

Group type: COMPARATOR
Intervention: MS-nurse consultation
Number of subjects: 48
Study: 22615318

Group type: EXPERIMENTAL
Intervention: Azithromycin treatment
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Doxycycline treatment
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Tinidazole treatment
Number of subjects: 293
Study: 19854001

Group type: EXPERIMENTAL
Intervention: Rapid attentional engagement toward social stress words
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Slow attentional engagement toward social stress words
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Fast engagers of social stress information
Number of subjects: 25

Group type: COMPARATOR
Intervention: Groups (fast and slow engagers)
Number of subjects: 25
Study: 17662790

Group type: EXPERIMENTAL
Intervention: Combined general and high thoracic epidural anesthesia (GA+TEA)
Number of subjects: 132

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 132
Study: 16247294

Group type: EXPERIMENTAL
Intervention: Genotypic testing
Number of subjects: 2165

Group type: COMPARATOR
Intervention: Phenotypic testing
Number of subjects: 2165
Study: 12406050

Group type: EXPERIMENTAL
Intervention: Usual care plus exercise (brisk walking intervention)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 52
Study: 10445378

Group type: EXPERIMENTAL
Intervention: Ipsapirone (0.3 mg/kg body weight)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 7559245

Group type: EXPERIMENTAL
Intervention: Heart Rate (HR) measured at various temperatures (22°C, 28°C, 32°C, 35°C) during exercise and rest periods.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: HR calculated at 22°C (HRcalc22) using individual regression lines.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Correction of HR for climate influence during rest and exercise.
Number of subjects: 20
Study: 2121079

Group type: EXPERIMENTAL
Intervention: Hyperoxic air (30% O2)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Normoxic air (21% O2)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Supplemental O2 (30% O2)
Number of subjects: 36
Study: 341905

Group type: EXPERIMENTAL
Intervention: Halopredone acetate cream (0.01%)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Betamethasone valerate (0.1%)
Number of subjects: 30
Study: 31811692

Group type: EXPERIMENTAL
Intervention: Language intervention
Number of subjects: 0
Study: 30953556

Group type: EXPERIMENTAL
Intervention: iBobbly app (self-help app based on acceptance and commitment therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: wait-list control condition
Number of subjects: 0
Study: 27807198

Group type: EXPERIMENTAL
Intervention: Oral doxycycline
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study: 24807396

Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil combined with fentanyl (FA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fentanyl alone (F)
Number of subjects: 40
Study: 23630367

Group type: EXPERIMENTAL
Intervention: Injection plus exercise (n = 115)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Exercise alone (n = 117)
Number of subjects: 232
Study: 22146167

Group type: EXPERIMENTAL
Intervention: Intra-abdominal pressure at 16 mm Hg (group 3)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intra-abdominal pressure at 10 mm Hg (group 1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intra-abdominal pressure at 13 mm Hg (group 2)
Number of subjects: 60
Study: 19250364

Group type: EXPERIMENTAL
Intervention: Early oxytocin group
Number of subjects: 630

Group type: COMPARATOR
Intervention: Expectant group (delayed oxytocin)
Number of subjects: 630
Study: 16479024

Group type: EXPERIMENTAL
Intervention: Vitamin D (0.25 mg/day)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 14757613

Group type: EXPERIMENTAL
Intervention: Regular aspirin use (> or =2 standard aspirin tablets/wk)
Number of subjects: 27077

Group type: EXPERIMENTAL
Intervention: Aspirin use of 0.5 to 1.5 standard tablets per week
Number of subjects: 27077

Group type: EXPERIMENTAL
Intervention: Aspirin use of 2 to 5 tablets per week
Number of subjects: 27077

Group type: EXPERIMENTAL
Intervention: Aspirin use of 6 to 14 tablets per week
Number of subjects: 27077

Group type: EXPERIMENTAL
Intervention: Aspirin use of more than 14 tablets per week
Number of subjects: 27077

Group type: EXPERIMENTAL
Intervention: Regular short-term aspirin use (< or =5 years)
Number of subjects: 27077

Group type: EXPERIMENTAL
Intervention: Regular long-term aspirin use (>5 years)
Number of subjects: 27077

Group type: EXPERIMENTAL
Intervention: Increasing duration of aspirin use
Number of subjects: 27077
Study: 11511404

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Amitriptyline 150 mg
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (Fluoxetine)
Number of subjects: 66
Study: 9699704

Group type: EXPERIMENTAL
Intervention: Paroxetine (N=31)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Nortriptyline (N=30)
Number of subjects: 61
Study: 7874151

Group type: EXPERIMENTAL
Intervention: Strenuous bout of resistive exercise (REx)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stationary cycling (AEx) at 50% peak VO2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (C) of quiet sitting
Number of subjects: 0
Study: 3074627

Group type: EXPERIMENTAL
Intervention: Thymic hormone
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Pentapeptide treatment
Number of subjects: 41

Group type: COMPARATOR
Intervention: Thymic therapy
Number of subjects: 41
Study: 31886683

Group type: EXPERIMENTAL
Intervention: Parenting in 2 Worlds (P2W)
Number of subjects: 575

Group type: COMPARATOR
Intervention: Healthy Families in 2 Worlds (HF2W)
Number of subjects: 575
Study: 29016984

Group type: EXPERIMENTAL
Intervention: Hidden conditioning
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Open conditioning
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 27697429

Group type: EXPERIMENTAL
Intervention: 14-week rehabilitation program (long duration)
Number of subjects: 66

Group type: COMPARATOR
Intervention: 7-week rehabilitation program (short duration)
Number of subjects: 66
Study: 26149602

Group type: EXPERIMENTAL
Intervention: FOLFOX-DEBIRI
Number of subjects: 70

Group type: COMPARATOR
Intervention: FOLFOX/bevacizumab
Number of subjects: 70
Study: 23758719

Group type: EXPERIMENTAL
Intervention: Sexual risk‐reduction intervention
Number of subjects: 26
Study: 20349684

Group type: EXPERIMENTAL
Intervention: adapalene 0.1%-benzoyl peroxide 2.5% (A/BPO) fixed-dose combination gel with doxycycline hyclate 100 mg
Number of subjects: 459

Group type: COMPARATOR
Intervention: vehicle
Number of subjects: 459
Study: 18490245

Group type: EXPERIMENTAL
Intervention: 8 Gy + zoledronic acid (4 mg iv, in 15‐min infusions)
Number of subjects: 139

Group type: COMPARATOR
Intervention: 6 Gy + zoledronic acid (4 mg iv, in 15‐min infusions)
Number of subjects: 139
Study: 15941414

Group type: EXPERIMENTAL
Intervention: Amodiaquine plus Artesunate (AQ/AS)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-Pyrimethamine (SP)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Chloroquine (CQ)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Amodiaquine (AQ)
Number of subjects: 240
Study: 12902587

Group type: EXPERIMENTAL
Intervention: Telephone Interviewer and Computerised Questionnaire Method (TICQM)
Number of subjects: 1162

Group type: COMPARATOR
Intervention: Telephone Interviewer Method (TIM)
Number of subjects: 1162

Group type: EXPERIMENTAL
Intervention: TICQM (for sexually active females)
Number of subjects: 1162

Group type: EXPERIMENTAL
Intervention: TICQM (for sexually active males)
Number of subjects: 1162
Study: 10497712

Group type: EXPERIMENTAL
Intervention: High-protein diet (22%)
Number of subjects: 10
Study: 8604620

Group type: EXPERIMENTAL
Intervention: Tissue plasminogen activator (TPA)
Number of subjects: 1473

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1473

Group type: EXPERIMENTAL
Intervention: Intravenous heparin titrated to an activated partial thromboplastin time (aPTT) of 1.5 to 2.0 times control for 72 to 96 hours
Number of subjects: 1473

Group type: EXPERIMENTAL
Intervention: Optimal anticoagulation (all aPTTs >60 seconds, all heparin levels>0.2 U/ml)
Number of subjects: 1473

Group type: EXPERIMENTAL
Intervention: Aggressive (high-intensity) anticoagulation with heparin to achieve aPTTs >2.0 times control
Number of subjects: 1473

Group type: EXPERIMENTAL
Intervention: Routine aPTT monitoring
Number of subjects: 1473

Group type: EXPERIMENTAL
Intervention: Antithrombotic therapy with heparin and aspirin
Number of subjects: 1473
Study: 1940267

Group type: EXPERIMENTAL
Intervention: Metoclopramide (20 mg intravenous)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 7004176

Group type: EXPERIMENTAL
Intervention: Tobramycin
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 31735645

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2 mA, 20 min) 5 times a week during the first month post stroke
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 50
Study: 30975961

Group type: EXPERIMENTAL
Intervention: Advanced platelet-rich fibrin (A-PRF)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Leukocyte- and platelet-rich fibrin (L-PRF)
Number of subjects: 27
Study: 28451764

Group type: EXPERIMENTAL
Intervention: Bioimpedance device (Group A)
Number of subjects: 96

Group type: COMPARATOR
Intervention: James formula (Group B)
Number of subjects: 96
Study: 25817849

Group type: EXPERIMENTAL
Intervention: Dexamethasone, 1 mg/kg, intravenous at induction of anesthesia
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 24308746

Group type: EXPERIMENTAL
Intervention: Single one-off education/exercise class for low risk patients
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 12 week group exercise/education intervention for medium risk patients
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 12 week group cognitive behavioural approach for high risk patients
Number of subjects: 47

Group type: COMPARATOR
Intervention: Generic group intervention for all patients in historical control group
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: All interventions (low, medium, high risk)
Number of subjects: 47
Study: 21318581

Group type: EXPERIMENTAL
Intervention: Transanal haemorrhoidal dearterialisation (THD)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Stapled haemorrhoidopexy (SH)
Number of subjects: 52
Study: 19500328

Group type: EXPERIMENTAL
Intervention: Microsatellite analysis (MA) of voided urine samples every 3 months with control cystoscopy at 3, 12, and 24 months
Number of subjects: 448

Group type: COMPARATOR
Intervention: Cystoscopy of the urinary bladder every 3 months (conventional arm)
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Microsatellite analysis (MA) of voided urine samples
Number of subjects: 448
Study: 16709935

Group type: EXPERIMENTAL
Intervention: Weight gain of 5% or less during the first 2 months of intensive phase therapy among underweight patients
Number of subjects: 857

Group type: COMPARATOR
Intervention: Underweight at diagnosis
Number of subjects: 857

Group type: COMPARATOR
Intervention: BMI less than 18.5 kg/m2
Number of subjects: 857
Study: 15250174

Group type: EXPERIMENTAL
Intervention: Durodont medical fresh and white (RDA 70)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Friscodent Zahnweiss (RDA 87)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combination of Durodont Zahnweiss intensiv (RDA 166) and Durodont medical fresh and white
Number of subjects: 36
Study: 11486443

Group type: EXPERIMENTAL
Intervention: Nasal dilators
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo strip
Number of subjects: 0
Study: 9272340

Group type: EXPERIMENTAL
Intervention: DTP-toxoids
Number of subjects: 3450

Group type: COMPARATOR
Intervention: DT-toxoids
Number of subjects: 3450
Study: 8339647

Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 3712681

Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 29883294

Group type: EXPERIMENTAL
Intervention: Autologous platelet-rich plasma (PRP)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Standard care (SoC)
Number of subjects: 8
Study: 26874390

Group type: EXPERIMENTAL
Intervention: Beetroot Juice (BRJ) - 6.1 mmol nitrate, daily for 1 week
Number of subjects: 20

Group type: COMPARATOR
Intervention: Beetroot Juice (BRJ) - 6.1 mmol nitrate, single acute dose
Number of subjects: 20
Study: 24886619

Group type: EXPERIMENTAL
Intervention: Sling exercise training (ST)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Continuous passive motion (CPM)
Number of subjects: 38
Study: 22269987

Group type: EXPERIMENTAL
Intervention: Workplace POWER program (n = 65)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Wait-list control group (n = 45)
Number of subjects: 110
Study: 20304352

Group type: EXPERIMENTAL
Intervention: Warmed ropivacaine (body temperature) 0.75%
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Warmed ropivacaine (body temperature)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Room temperature ropivacaine
Number of subjects: 180
Study: 17116056

Group type: EXPERIMENTAL
Intervention: Antenatal day care
Number of subjects: 395

Group type: COMPARATOR
Intervention: Antenatal ward (control)
Number of subjects: 395
Study: 14730655

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 50 mcg twice daily (FP 100)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 125 mcg twice daily (FP 250)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 11344825

Group type: EXPERIMENTAL
Intervention: HRT (cyclical conjugated estrogens 0.625 mg/day plus medrogestone 5 mg/day)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: HRT
Number of subjects: 54
Study: 9150627

Group type: EXPERIMENTAL
Intervention: Intervention II
Number of subjects: 0
Study: 8217793

Group type: EXPERIMENTAL
Intervention: Transfer Factor (TF)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (no TF)
Number of subjects: 22
Study: 3622582

Group type: COMPARATOR
Intervention: delta-sleep-inducing peptide (DSIP)
Number of subjects: 14

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study: 31834156

Group type: EXPERIMENTAL
Intervention: Intravaginal ovule containing 0.03mg estriol, treated daily for 16 weeks (Group A)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 96
Study: 30316952

Group type: EXPERIMENTAL
Intervention: Early ICU-team review
Number of subjects: 205
Study: 28030601

Group type: EXPERIMENTAL
Intervention: Normal ionized calcium target range (1.1‐1.2 mmol/l)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low ionized calcium target range (0.95‐1.05 mmol/l)
Number of subjects: 30
Study: 24411798

Group type: EXPERIMENTAL
Intervention: Perceived positive school climates
Number of subjects: 361

Group type: COMPARATOR
Intervention: Perceived student drug testing
Number of subjects: 361